Literature DB >> 12023372

Matrix fibronectin increases HIV stability and infectivity.

Giampaolo Greco1, Sampa Pal, Renata Pasqualini, Lynn M Schnapp.   

Abstract

HIV particles are detected extracellularly in lymphoid tissues, a major reservoir of the virus. We previously reported that a polymerized form of fibronectin (FN), superfibronectin (sFN), as well as a fragment of FN, III1-C, enhanced infection of primary CD4(+) T cells by HIV-1IIIB. We now show that sFN enhances infection of primary CD4(+) T cells by both R5 and X4 strains of HIV-1. Using HIV pseudotyped with different envelope glycoproteins (gp120) and HOS cells transfected with various chemokine receptors alone or in combination with the CD4 molecule, we show that sFN-mediated enhancement requires the CD4 receptor and does not alter the specificity of gp120 for different chemokine receptors. Because the III1-C fragment also resulted in enhancement, we asked whether proteolysis of FN generated fragments capable of enhancing HIV infection. We found that progressive proteolysis of FN by chymotrypsin correlates with an enhancement of HIV infection in both primary CD4(+) T cells and the IG5 reporter cell line. Furthermore, incubation of HIV with sFN significantly prolonged infectivity at 37 degrees C compared with dimeric FN or BSA. In conclusion, these results indicate that polymerized (matrix) or degraded (inflammation-associated), but not dimeric (plasma), FN are capable of enhancing infection by HIV-1, independent of the coreceptor specificity of the strains. Moreover, virions bound to matrix FN maintain infectivity for longer periods of time than do virions in suspension. This study suggests that matrix proteins and their conformational status may play a role in the pathogenesis of HIV.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12023372     DOI: 10.4049/jimmunol.168.11.5722

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  15 in total

1.  Entry kinetics and cell-cell transmission of surface-bound retroviral vector particles.

Authors:  Lee S O'Neill; Amy M Skinner; Josha A Woodward; Peter Kurre
Journal:  J Gene Med       Date:  2010-05       Impact factor: 4.565

Review 2.  Monocytes mediate HIV neuropathogenesis: mechanisms that contribute to HIV associated neurocognitive disorders.

Authors:  Dionna W Williams; Mike Veenstra; Peter J Gaskill; Susan Morgello; Tina M Calderon; Joan W Berman
Journal:  Curr HIV Res       Date:  2014       Impact factor: 1.581

3.  Short communication: adhesion pathways utilized by HIV-infected lymphocytes.

Authors:  Yu-hua Chow; Li Liu; Barbara Schwartz; John M Harlan; Lynn M Schnapp
Journal:  AIDS Res Hum Retroviruses       Date:  2012-04-13       Impact factor: 2.205

4.  Extracellular Matrix Proteins Mediate HIV-1 gp120 Interactions with α4β7.

Authors:  David Plotnik; Wenjin Guo; Brad Cleveland; Priska von Haller; Jimmy K Eng; Miklos Guttman; Kelly K Lee; James Arthos; Shiu-Lok Hu
Journal:  J Virol       Date:  2017-10-13       Impact factor: 5.103

5.  Biochemical and biologic characterization of exosomes and microvesicles as facilitators of HIV-1 infection in macrophages.

Authors:  Irena Kadiu; Prabagaran Narayanasamy; Prasanta K Dash; Wei Zhang; Howard E Gendelman
Journal:  J Immunol       Date:  2012-06-18       Impact factor: 5.422

6.  Characterization of monocyte maturation/differentiation that facilitates their transmigration across the blood-brain barrier and infection by HIV: implications for NeuroAIDS.

Authors:  Clarisa M Buckner; Tina M Calderon; Dionna W Willams; Thomas J Belbin; Joan W Berman
Journal:  Cell Immunol       Date:  2010-12-25       Impact factor: 4.868

7.  Monocyte CD49e and 110-120 kDa fibronectin fragments: HIV prognostic indicators independent of viral load and CD4 T-cell counts.

Authors:  Roger D Rossen; Jose A Rubio; Wendy J Porter; JoAnn Trial; Frank M Orson; Maria C Rodriguez-Barradas; Holly H Birdsall
Journal:  AIDS       Date:  2009-11-13       Impact factor: 4.177

8.  Matrix fibronectin binds gammaretrovirus and assists in entry: new light on viral infections.

Authors:  Christiane Beer; Lene Pedersen
Journal:  J Virol       Date:  2007-05-23       Impact factor: 5.103

9.  Shedding of clinical-grade lentiviral vectors is not detected in a gene therapy setting.

Authors:  M Cesani; T Plati; L Lorioli; F Benedicenti; D Redaelli; F Dionisio; L Biasco; E Montini; L Naldini; A Biffi
Journal:  Gene Ther       Date:  2015-03-12       Impact factor: 5.250

10.  Slit2/Robo4 signaling modulates HIV-1 gp120-induced lymphatic hyperpermeability.

Authors:  Xuefeng Zhang; Jinlong Yu; Paula M Kuzontkoski; Weiquan Zhu; Dean Y Li; Jerome E Groopman
Journal:  PLoS Pathog       Date:  2012-01-05       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.